PeptiDreamPeptiDream Inc.4587東証プライム医薬品FY ending Dec 2024, consolidated, IFRS

PeptiDream FY ending Dec 2019 results

PeptiDream brought in ¥1.04B in revenue.

It lost about ¥86 for every ¥100 of sales at the operating level.

Where the money goes

Where ¥100 of sales goes

For every ¥100 PeptiDream sells, how much goes where, and how much is kept.

FY ending Dec 2019
Cost of sales
¥65
SG&A
¥121
Operating loss
¥86
Net loss
¥47

Margin funnel (derived from reported values)Gross margin 35.3% → Operating margin -85.5% → Net margin -47.1%

Sources

Show source documents (2)
  • EDINET (FSA Japan)

    有価証券報告書-第16期(令和3年1月1日-令和3年12月31日)

    ID S100NQLE2022-03-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第15期(令和2年1月1日-令和2年12月31日)

    ID S100L1B02021-03-26Open

Extracted from XBRL: 33 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.